Stock Research: Masimo

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

Masimo

NasdaqGS:MASI US5747951003
22
  • Value
    23
  • Growth
    61
  • Safety
    Safety
    30
  • Combined
    16
  • Sentiment
    37
  • 360° View
    360° View
    22
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Masimo Corporation develops, manufactures, and markets patient monitoring technologies and automation solutions. It operates in healthcare and non-healthcare segments, with products including monitors, sensors, and software. The company's healthcare products are sold to hospitals and other healthcare providers. Its non-healthcare business includes audio and home integration technologies. In the last fiscal year, the company had a market cap of $8,704 million, profits of $1,004 million, and revenue of $2,094 million with 3600 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 22 (better than 22% compared with alternatives), overall professional sentiment and financial characteristics for the stock Masimo are critical, mostly below average. The 360° View is based on consolidating four consolidated indicators, with three out of four indicators below average for Masimo. The consolidated Growth Rank has a good rank of 61, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth, as well as stock returns. It ranks higher than 61% of competitors in the same industry. The other indicators are below average, namely the Value, Safety, and Sentiment Ranks.The Value Rank at 30 means that the share price of Masimo is on the high side compared with its peers regarding revenues, profits, and invested capital. The stock price is higher than for 70% of alternative stocks in the same industry. The consolidated Safety Rank has a riskier rank of 23, which means that the company has a riskier financing structure than 77% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. The consolidated Sentiment Rank also has a low rank of 37, indicating professional investors are more pessimistic about the stock than for 63% of alternative investment opportunities. ...read more

more
Index
NASDAQ
D.J. US Medical Equipment
S&P MIDCAP
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 30-Oct-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
30 25 34 19
Growth
61 77 31 27
Safety
Safety
23 28 34 98
Sentiment
37 37 34 74
360° View
360° View
22 31 1 62
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
73 65 47 20
Opinions Change
37 50 50 50
Pro Holdings
n/a 58 51 78
Market Pulse
31 29 26 77
Sentiment
37 37 34 74
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
30 25 34 19
Growth
61 77 31 27
Safety Safety
23 28 34 98
Combined
16 34 15 38
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
50 20 19 21
Price vs. Earnings (P/E)
29 38 56 23
Price vs. Book (P/B)
25 37 44 43
Dividend Yield
1 1 1 1
Value
30 25 34 19
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
42 12 10 35
Profit Growth
82 78 15 37
Capital Growth
38 86 93 47
Stock Returns
59 77 45 55
Growth
61 77 31 27
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
38 44 30 100
Refinancing
29 16 27 31
Liquidity
45 66 76 98
Safety Safety
23 28 34 98

Similar Stocks

Discover high‑ranked alternatives to Masimo and broaden your portfolio horizons.

Meta

NasdaqGS:FB
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Cognizant Technology

NasdaqGS:CTSH
Country: USA
Industry: IT Consulting & oth. Services
Size: X-Large
Full Stock Analysis

Cigna

NYSE:CI
Country: USA
Industry: Health Care Services
Size: XX-Large
Full Stock Analysis

Spectrum Brands

NYSE:SPB
Country: USA
Industry: Household Products
Size: Medium
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.